Published in Aliment Pharmacol Ther on November 01, 2012
Letter: Supporting Austrian guidelines on latent tuberculosis screening. Aliment Pharmacol Ther (2013) 0.98
Letter: Recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings. Aliment Pharmacol Ther (2013) 0.96
Follow-up testing of interferon-gamma release assays are useful in ankylosing spondylitis patients receiving anti-tumor necrosis factor alpha for latent tuberculosis infection. J Korean Med Sci (2014) 0.82
Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy. Ann Gastroenterol (2015) 0.75
Letter: Recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings--author's reply. Aliment Pharmacol Ther (2013) 0.75
The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol (1999) 6.27
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J (2010) 4.72
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet (1993) 3.42
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22
Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther (2013) 2.90
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55
Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology (1991) 2.42
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation. Int J Clin Pract (2011) 2.25
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Aliment Pharmacol Ther (2015) 2.25
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study. Allergy (2012) 1.88
Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop Med Parasitol (1995) 1.85
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis. J Intern Med (2008) 1.68
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med (1999) 1.62
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol (1999) 1.61
Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. J Allergy Clin Immunol (2000) 1.60
Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A. Nephrol Dial Transplant (1997) 1.60
Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology (2001) 1.56
Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease. Endoscopy (1998) 1.53
Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis (1994) 1.53
High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1996) 1.45
Six3 overexpression initiates the formation of ectopic retina. Genes Dev (1999) 1.42
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy (2009) 1.41
High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis. Rheumatology (Oxford) (2005) 1.41
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet (2004) 1.38
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res (1994) 1.36
Review article: the role of anti-TNF in the management of ulcerative colitis -- past, present and future. Aliment Pharmacol Ther (2013) 1.32
Medaka eyeless is the key factor linking retinal determination and eye growth. Development (2001) 1.32
DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods (2001) 1.30
Metabolization of beta-(2,6)-linked fructose-oligosaccharides by different bifidobacteria. FEMS Microbiol Lett (2000) 1.28
Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology (1997) 1.27
Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut (2005) 1.24
Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther (2011) 1.22
Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer. Int J Cancer (1996) 1.22
Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg (1995) 1.21
Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med (1999) 1.19
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
Implant survival in patients with type 2 diabetes: placement to 36 months. Ann Periodontol (2000) 1.15
Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history. Am J Pathol (1995) 1.15
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease. J Crohns Colitis (2012) 1.15
Dentinogenesis imperfecta traceable through five generations of a part American Indian family. Oral Surg Oral Med Oral Pathol (1973) 1.13
Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med (1997) 1.12
[Therapy of active Crohn disease with Boswellia serrata extract H 15]. Z Gastroenterol (2001) 1.12
Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol (2003) 1.10
Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg (1996) 1.10
Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol (1999) 1.10
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut (2007) 1.09
Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab (1999) 1.08
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. J Crohns Colitis (2010) 1.08
Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res (1996) 1.08
Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci (2003) 1.07
Transhepatic metabolism of TNF-alpha, IL-6, and endotoxin in the early hepatic reperfusion period after human liver transplantation. Transplantation (1994) 1.07
Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg (1993) 1.06
Electrophysiological correlates of direct versus indirect semantic priming in normal volunteers. Brain Res Cogn Brain Res (1999) 1.06
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment Pharmacol Ther (2003) 1.06
Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci (1994) 1.06
Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr (2007) 1.05
Reduction-oxidation control of beta-sheet assembly in genetically engineered silk. Biomacromolecules (2000) 1.05
Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med (1997) 1.05
IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol (2000) 1.05
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy. Aliment Pharmacol Ther (2011) 1.05
Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures. Endoscopy (2006) 1.04
Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J Neurosci (1999) 1.04
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology (2008) 1.03
Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol (1997) 1.03
Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther (2003) 1.03
In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Antimicrob Agents Chemother (2003) 1.03
Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70. FASEB J (1999) 1.02
Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol (1999) 1.01
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract. Inflamm Bowel Dis (2001) 1.00
Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am J Pathol (1996) 1.00
Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease. Dig Dis Sci (1995) 1.00
Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer (1995) 1.00
Isolated endocarditis of the pulmonary valve caused by Pasteurella multocida. Infection (2007) 1.00
Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol (1999) 0.99
Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis. Clin Immunol Immunopathol (1996) 0.99
Charged and metallic molecular monolayers through surface-induced aromatic stabilization. Nat Chem (2013) 0.98
L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism. Transplantation (1994) 0.98
Significant association of strictures and internal fistula formation in Crohn's disease. Virchows Arch (2000) 0.98